252
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Vaginal probiotics on the outcomes of premature rupture of membranes: a pilot randomised clinical trial

, & ORCID Icon
Pages 3527-3530 | Received 23 Mar 2022, Accepted 21 Nov 2022, Published online: 12 Jan 2023

References

  • Álvarez-Calatayud, G., et al., 2015. Microbiota in women; clinical applications of probiotics. Nutricion Hospitalaria, 32(Suppl. 1):56–61.
  • Andreu, A., 2004. Lactobacillus as a probiotic for preventing urogenital infections. Reviews in Medical Microbiology, 15 (1), 1–6.
  • Arango, L.F., et al., 2015. Probiotics and pregnancy. Current Diabetes Reports, 15 (1), 567.
  • Baldassarre, M.E., et al., 2019. Dysbiosis and prematurity: Is there a role for probiotics? Nutrients, 11 (6), 1273.
  • Barthow, C., et al., 2016. The Probiotics in Pregnancy Study (PiP Study); rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy. BMC Pregnancy and Childbirth, 16 (1), 133.
  • Daskalakis, G.J. and Karambelas, A.K., 2017. Vaginal probiotic administration in the management of preterm premature rupture of membranes. Fetal Diagnosis and Therapy, 42 (2), 92–98.
  • Di Pierro, F., et al., 2016. Positive clinical outcomes derived from using a proprietary mixture of selected strains during pregnancy. Acta Bio-Medica: Atenei Parmensis, 87 (3), 259–265.
  • Genovese, C., et al., 2016. Alterations of the vaginal microbiota in the third trimester of pregnancy and pPROM. European Review for Medical and Pharmacological Sciences, 20 (16), 3336–3343.
  • Gille, C., et al., 2016. Effect of probiotics on vaginal health in pregnancy. EFFPRO, a randomized controlled trial. American Journal of Obstetrics and Gynecology, 215 (5), 608.e1-7–608.e7.
  • Jarde, A., et al., 2018. Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis. BMC Pregnancy and Childbirth, 18 (1), 14.
  • Kavak, S.B., et al., 2022. Evaluation of the effectiveness of Ampicillin and Lactobacillus casei rhamnosus treatment in cases of preterm premature rupture of membranes remote from term. Ginekologia Polska, 93 (6), 482–488.
  • Kavak, S.B., et al., 2014. The efficacy of ampicillin and Lactobacillus casei rhamnosus in the active management of preterm premature rupture of membranes remote from term. Drug Design, Development and Therapy, 8 (8), 1169–1173.
  • Kilbride, H.W. and Thibeault, D.W., 2001. Neonatal complications of preterm premature rupture of membranes. Clinics in Perinatology, 28 (4), 761–785.
  • Kim, C.J., et al., 2015. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. American Journal of Obstetrics and Gynecology, 213 (4), S29–S52.
  • Luoto, R., et al., 2010. Impact of maternal probiotic supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. The British Journal of Nutrition, 103 (12), 1792–1799.
  • Mcfarland, L.V., 2014. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open, 4 (8), e005047.
  • McGregor, J.A. and French, J.I., 1997. Pathogenesis to treatment: preventing preterm birth mediated by infection. Infectious Diseases in Obstetrics and Gynecology, 5 (2), 106–114.
  • Morris, J.M., et al., 2016. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. The Lancet, 387 (10017), 444–452.
  • Nayot, D., et al., 2012. Neonatal outcomes are associated with latency after preterm premature rupture of membranes. Journal of Perinatology, 32 (12), 970–977.
  • Neuman, H. and Koren, O., 2017. The pregnancy microbiome. Nestle Nutrition Institute Workshop Series, 88, 1–9.
  • Nugent, R.P., Krohn, M.A. and Hillier, S.L., 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology, 29 (2), 297–301.
  • Othman, M., Alfirevic, Z. and Neilson, J.P., 2007. Probiotics for preventing preterm labour. The Cochrane Database of Systematic Reviews, 2007 (1), CD005941.
  • Priestley, C.J., et al., 1997. What is normal vaginal flora? Genitourinary Medicine, 73 (1), 23–28.
  • Reid, G. and Bocking, A., 2003. The potential for probiotics to prevent bacterial vaginosis and preterm labor. American Journal of Obstetrics and Gynecology, 189 (4), 1202–1208.
  • Sandeford, J., et al., 2021. Protocol for probiotic therapy vs placebo for preterm prelabour rupture of membranes to prolong pregnancy duration (Pro-PPROM) trial. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 61 (2), E12–E17.
  • Solt, I., 2015. The human microbiome and the great obstetrical syndromes: A new frontier in maternal-fetal medicine. Best Practice & Research-Clinical Obstetrics & Gynaecology, 29 (2), 165–175.
  • Thomas, L.V., Ockhuizen, T. and Suzuki, K., 2014. Exploring the influence of the gut microbiota and probiotics on health: a symposium report. British Journal of Nutrition, 112 (S1), S1–S18.
  • Yadav, J., et al., 2022. Vaginal probiotics as an adjunct to antibiotic prophylaxis in the management of preterm premature rupture of the membranes. Journal of Obstetrics and Gynecology, 12, 1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.